- Home
- FPH vs LRMR Comparison
FPH vs LRMR Comparison
Compare FPH & LRMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FPH | LRMR |
|---|---|---|
| Founded | 2009 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 376.2M | 280.0M |
| IPO Year | 2013 | 2014 |
Fundamental Metrics
Financial Performance| Metric | FPH | LRMR |
|---|---|---|
| Price | $5.52 | $5.51 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 7 |
| Target Price | N/A | ★ $16.14 |
| AVG Volume (30 Days) | 192.7K | ★ 6.0M |
| Earning Date | 04-29-2026 | 04-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $237,926,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $11.40 | ★ N/A |
| Revenue Growth | ★ 12.37 | N/A |
| 52 Week Low | $4.58 | $1.61 |
| 52 Week High | $6.64 | $6.42 |
Technical Indicators
Market Signals| Indicator | FPH | LRMR |
|---|---|---|
| Relative Strength Index (RSI) | 52.20 | 69.97 |
| Support Level | $5.36 | $3.18 |
| Resistance Level | $5.75 | N/A |
| Average True Range (ATR) | 0.21 | 0.48 |
| MACD | 0.03 | 0.27 |
| Stochastic Oscillator | 63.64 | 75.30 |
Price Performance
Historical ComparisonAbout FPH Five Point Holdings LLC
Five Point Holdings LLC is an owner and developer of mixed-use, master-planned communities in California. It is engaged in developing new communities that, in addition to homesites, include commercial, retail, educational, and recreational elements, as well as civic areas, parks, and open spaces. Its three reportable segments are Valencia, San Francisco, and Great Park. It derives the majority of revenue from the Great Park segment which includes Great Park Neighborhoods being developed adjacent to and around the Orange County Great Park, a metropolitan park under construction in Orange County, California.
About LRMR Larimar Therapeutics Inc.
Larimar Therapeutics Inc is a clinical-stage biotechnology company focused on developing treatments for patients suffering from complex rare diseases using its novel cell-penetrating peptide (CPP) technology platform. Its lead product candidate, CTI-1601, is a subcutaneously administered, recombinant fusion protein intended to deliver human frataxin (FXN) an essential protein, to the mitochondria of patients with Friedreich's ataxia.